A fatal post-COVID-19 sino-orbital mucormycosis in an adult patient with diabetes mellitus: a case report and review of the literature
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.16526 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Yousef Moghdam und 8 weiteren Autor:innen. Beteiligte Einrichtung: Khatam al-Anbia Hospital, Golestan Social Security Management, Golestan Province, Gonbad Kavus, Iran. Hauptthemen laut MEDLINE: Mucormycosis, COVID-19, Orbital Diseases, Diabetes Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
COVID-19 is associated with a broad spectrum of bacterial and fungal superinfections. Case Presentation: We present a case of mucormycosis developing during post-COVID-19 therapeutic management. A 63-year-old diabetic female presented with COVID-19 and received combination therapy per institutional protocol, including dexamethasone, remdesivir, and ivermectin. Seven days post-discharge, the patient was readmitted with dyspnea and lethargy. On day 3 of readmission, the patient reported unilateral facial and orbital pain. Subsequent histopathological and mycological examination confirmed mucormycosis. Despite surgical debridement and treatment with amphotericin B (3 mg/kg/day), the patient succumbed to the infection.
Results
Based on ITS rDNA sequencing, the fungus was identified as Rhizopus arrhizus. Antifungal susceptibility testing was performed according to the CLSI M38-A2 guideline, yielding minimum inhibitory concentration (MIC) values of 0.016 µg/mL for amphotericin B, 0.031 µg/mL for posaconazole, 0.25 µg/mL for isavuconazole, 1 µg/mL for itraconazole, and 8 µg/mL for voriconazole.
Conclusions
Early diagnosis, prompt antifungal therapy, and appropriate surgical intervention are critical for improving mucormycosis outcomes, especially in COVID-19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Khatam al-Anbia Hospital, Golestan Social Security Management, Golestan Province, Gonbad Kavus, Iran .
- Department of Basic Medical Sciences, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran.
- Department of Parasitology and Medical Mycology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
- Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
- Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
- Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Zitieren
APA
Moghdam, Y., Arghavan, B., Kermani, F., Jeddi, S. A., Khojasteh, S., Shokohi, T., Aslani, N., Ebrahimi, A., & Javidnia, J. (2025). A fatal post-COVID-19 sino-orbital mucormycosis in an adult patient with diabetes mellitus: a case report and review of the literature. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.16526
Vancouver
Moghdam Y, Arghavan B, Kermani F, Jeddi SA, Khojasteh S, Shokohi T, et al. A fatal post-COVID-19 sino-orbital mucormycosis in an adult patient with diabetes mellitus: a case report and review of the literature. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.16526
BibTeX
@article{Moghdam2025,
author = {Moghdam, Yousef and Arghavan, Bahareh and Kermani, Firoozeh and Jeddi, Seyed Ali and Khojasteh, Shaghayegh and Shokohi, Tahereh and Aslani, Narges and Ebrahimi, Abolghasem and Javidnia, Javad},
title = {A fatal post-COVID-19 sino-orbital mucormycosis in an adult patient with diabetes mellitus: a case report and review of the literature},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.16526}
}
EUVIMED